Free Trial

Teleflex (TFX) Stock Price, News & Analysis

-3.76 (-1.76%)
(As of 12:09 PM ET)
Today's Range
50-Day Range
52-Week Range
560,145 shs
Average Volume
314,578 shs
Market Capitalization
$9.86 billion
P/E Ratio
Dividend Yield
Price Target

Teleflex MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.67 Rating Score
25.0% Upside
$261.75 Price Target
Short Interest
1.25% of Shares Sold Short
Dividend Strength
Based on Four Factors
Upright™ Environmental Score
News Sentiment
0.90mentions of Teleflex in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$1.67 M Sold Last Quarter
Proj. Earnings Growth
From $13.75 to $15.17 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.81 out of 5 stars

Medical Sector

52nd out of 921 stocks

Surgical & Medical Instruments Industry

11th out of 99 stocks

TFX stock logo

About Teleflex Stock (NYSE:TFX)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. The company provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. It also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings; urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

TFX Stock Price History

TFX Stock News Headlines

Teleflex Publishes 2023 Global Impact Report
Teleflex Announces Quarterly Dividend
How Is The Market Feeling About Teleflex?
Teleflex Q1 Results Top Estimates: Boosts FY24 Adj. EPS Outlook
Here's what to expect from Teleflex's earnings report
See More Headlines
Receive TFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teleflex and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 3/15 Dividend
Dividend Payable
Last Earnings
Ex-Dividend for 6/14 Dividend
Dividend Payable
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Health Care Equipment
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
9 Analysts


Net Income
$356.33 million
Pretax Margin


Sales & Book Value

Annual Sales
$2.97 billion
Cash Flow
$18.69 per share
Book Value
$95.60 per share


Free Float
Market Cap
$10.04 billion

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

TFX Stock Analysis - Frequently Asked Questions

Should I buy or sell Teleflex stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teleflex in the last twelve months. There are currently 3 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TFX shares.
View TFX analyst ratings
or view top-rated stocks.

What is Teleflex's stock price target for 2024?

9 analysts have issued 1-year price targets for Teleflex's stock. Their TFX share price targets range from $219.00 to $293.00. On average, they expect the company's share price to reach $261.75 in the next twelve months. This suggests a possible upside of 25.0% from the stock's current price.
View analysts price targets for TFX
or view top-rated stocks among Wall Street analysts.

How have TFX shares performed in 2024?

Teleflex's stock was trading at $249.34 at the start of the year. Since then, TFX stock has decreased by 16.0% and is now trading at $209.43.
View the best growth stocks for 2024 here

Are investors shorting Teleflex?

Teleflex saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 590,300 shares, a drop of 17.1% from the April 15th total of 712,200 shares. Based on an average daily volume of 321,800 shares, the days-to-cover ratio is currently 1.8 days.
View Teleflex's Short Interest

When is Teleflex's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024.
View our TFX earnings forecast

How were Teleflex's earnings last quarter?

Teleflex Incorporated (NYSE:TFX) announced its quarterly earnings data on Thursday, May, 2nd. The medical technology company reported $3.21 earnings per share for the quarter, topping the consensus estimate of $3.07 by $0.14. The medical technology company earned $737.80 million during the quarter, compared to analysts' expectations of $726.85 million. Teleflex had a trailing twelve-month return on equity of 14.78% and a net margin of 9.82%. Teleflex's revenue was up 3.8% on a year-over-year basis. During the same quarter last year, the company posted $3.09 earnings per share.
Read the conference call transcript

How often does Teleflex pay dividends? What is the dividend yield for Teleflex?

Teleflex declared a quarterly dividend on Monday, May 6th. Investors of record on Wednesday, May 15th will be given a dividend of $0.34 per share on Friday, June 14th. This represents a $1.36 annualized dividend and a dividend yield of 0.65%. The ex-dividend date is Tuesday, May 14th.
Read our dividend analysis for TFX

Is Teleflex a good dividend stock?

Teleflex (NYSE:TFX) pays an annual dividend of $1.36 per share and currently has a dividend yield of 0.64%. The dividend payout ratio is 21.83%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, TFX will have a dividend payout ratio of 8.97% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for TFX.

What guidance has Teleflex issued on next quarter's earnings?

Teleflex issued an update on its FY 2024 earnings guidance on Friday, May, 3rd. The company provided earnings per share guidance of 13.600-13.950 for the period, compared to the consensus EPS estimate of 13.730. The company issued revenue guidance of $3.1 billion-$3.1 billion, compared to the consensus revenue estimate of $3.1 billion.

What is Liam Kelly's approval rating as Teleflex's CEO?

73 employees have rated Teleflex Chief Executive Officer Liam Kelly on Liam Kelly has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Teleflex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teleflex investors own include NVIDIA (NVDA), AbbVie (ABBV), Johnson & Johnson (JNJ), Alibaba Group (BABA), Lam Research (LRCX), ServiceNow (NOW), QUALCOMM (QCOM), Advanced Micro Devices (AMD), Salesforce (CRM) and Cisco Systems (CSCO).

Who are Teleflex's major shareholders?

Teleflex's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (11.78%), Janus Henderson Group PLC (11.48%), Price T Rowe Associates Inc. MD (2.81%), TD Asset Management Inc (0.86%), Bessemer Group Inc. (0.81%) and Villere ST Denis J & Co. LLC (0.35%). Insiders that own company stock include Andrew A Krakauer, Cameron P Hicks, Liam Kelly, Stephen K MD Klasko, Stephen K MD Klasko, Stuart A Randle and Thomas E Powell.
View institutional ownership trends

How do I buy shares of Teleflex?

Shares of TFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:TFX) was last updated on 5/23/2024 by Staff

From Our Partners